Citation
Liqing Li, Zhitao Lin, Junbao Wei. Metabolic–clinical subtypes predict survival in BCLC-C hepatocellular carcinoma receiving synchronous TACE plus targeted and immunotherapy. // BMC Cancer. – 2026. – DOI: 10.1186/s12885-026-17335-x. – URL: https://doi.org/10.1186/s12885-026-17335-x
Liqing Li, Zhitao Lin, & Junbao Wei (2026). Metabolic–clinical subtypes predict survival in BCLC-C hepatocellular carcinoma receiving synchronous TACE plus targeted and immunotherapy. BMC Cancer. https://doi.org/10.1186/s12885-026-17335-x
Liqing Li, et al. “Metabolic–clinical subtypes predict survival in BCLC-C hepatocellular carcinoma receiving synchronous TACE plus targeted and immunotherapy.” BMC Cancer, 2026. doi:10.1186/s12885-026-17335-x.
@article{Li2026,
title = {Metabolic–clinical subtypes predict survival in BCLC-C hepatocellular carcinoma receiving synchronous TACE plus targeted and immunotherapy},
author = {Li, Liqing and Lin, Zhitao and Wei, Junbao},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-17335-x},
url = {https://doi.org/10.1186/s12885-026-17335-x}
}